These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1691671)

  • 1. Effects of a selective 5-HT2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphe nucleus and 5-HT release and metabolism in the frontal cortex.
    Wright IK; Garratt JC; Marsden CA
    Br J Pharmacol; 1990 Feb; 99(2):221-2. PubMed ID: 1691671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI.
    Garratt JC; Kidd EJ; Wright IK; Marsden CA
    Eur J Pharmacol; 1991 Jul; 199(3):349-55. PubMed ID: 1915582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of repeated treatment with 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on the autoregulatory control of dorsal raphe 5-HT neuronal firing and cortical 5-HT release.
    Kidd EJ; Garratt JC; Marsden CA
    Eur J Pharmacol; 1991 Jul; 200(1):131-9. PubMed ID: 1837523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.
    Adell A; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):237-44. PubMed ID: 1714040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function.
    Garratt JC; Crespi F; Mason R; Marsden CA
    Eur J Pharmacol; 1991 Jan; 193(1):87-93. PubMed ID: 1710990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine.
    Blier P; Serrano A; Scatton B
    Synapse; 1990; 5(2):120-33. PubMed ID: 2137943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism.
    Crespi F; Garratt JC; Sleight AJ; Marsden CA
    Neuroscience; 1990; 35(1):139-44. PubMed ID: 1694283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.
    Celada P; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):583-90. PubMed ID: 7689703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin.
    Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
    Eur J Pharmacol; 1989 Aug; 167(3):375-83. PubMed ID: 2572435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.
    Series HG; Cowen PJ; Sharp T
    Psychopharmacology (Berl); 1994 Dec; 116(4):508-14. PubMed ID: 7535469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P; Nomikos GG; Svensson TH
    Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent effects of cholinergic and serotonergic lesions on acetylcholine and serotonin release in the neocortex of the rat.
    Dekker AJ; Thal LJ
    Neurochem Res; 1993 Mar; 18(3):277-83. PubMed ID: 7683117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo.
    O'Connell MT; Portas CM; Sarna GS; Curzon G
    Br J Pharmacol; 1991 Apr; 102(4):831-6. PubMed ID: 1713108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan.
    Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
    Eur J Pharmacol; 1990 Mar; 178(3):313-20. PubMed ID: 1971220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat.
    Boothman LJ; Allers KA; Rasmussen K; Sharp T
    Br J Pharmacol; 2003 Jul; 139(5):998-1004. PubMed ID: 12839874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study.
    Bel N; Artigas F
    Eur J Pharmacol; 1992 Dec; 229(1):101-3. PubMed ID: 1282104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of corticotropin-releasing factor on brain serotonergic activity.
    Price ML; Curtis AL; Kirby LG; Valentino RJ; Lucki I
    Neuropsychopharmacology; 1998 Jun; 18(6):492-502. PubMed ID: 9571657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic and GABAergic mediations of the effects of apomorphine on serotonin neurons.
    Chen HY; Lin YP; Lee EH
    Synapse; 1992 Jan; 10(1):34-43. PubMed ID: 1371366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording studies.
    Cunningham KA; Lakoski JM
    Neuropsychopharmacology; 1990 Feb; 3(1):41-50. PubMed ID: 2137698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of medullary serotonin neurons.
    Clement ME; McCall RB
    Brain Res; 1991 Mar; 542(2):205-11. PubMed ID: 2029631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.